Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Sundry Debtors ₹4,099 Cr₹3,101 Cr₹2,572 Cr₹2,409 Cr₹2,195 Cr

What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS is ₹4,099 Cr based on Mar2023 Consolidated results.
Year Sundry Debtors
Mar2023₹4,099 Cr
Mar2022₹3,101 Cr
Mar2021₹2,572 Cr
Mar2020₹2,409 Cr
Mar2019₹2,195 Cr

How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2023 ₹4,099 Cr
32.16
Mar2022 ₹3,101 Cr
20.57
Mar2021 ₹2,572 Cr
6.77
Mar2020 ₹2,409 Cr
9.77
Mar2019 ₹2,195 Cr -

Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹29,743.9 Cr -2.4% 7.4% 88% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.4%

7.4%

88%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses